
Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis
Keywords: angioplasty; restenosis; sirolimus; stents; malignanciesDES, drug-eluting stent(s); ISR, in-stent restenosis; MI, myocardial infarction; PCI, percutaneous coronary intervention; TVR, target vessel revascularization